CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
231 hedge funds and large institutions have $6.42B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 82 increasing their positions, 69 reducing their positions, and 20 closing their positions.
Holders
231
Holders Change
+21
Holders Change %
+10%
% of All Funds
3.36%
Holding in Top 10
16
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+60%
% of All Funds
0.23%
New
43
Increased
82
Reduced
69
Closed
20
Calls
$149M
Puts
$169M
Net Calls
-$20.1M
Net Calls Change
-$33.1M
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$146M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$200K |
| 3 |
UOC
3
UBS O'Connor
Chicago,
Illinois
|
$81.8M |
| 4 |
BBA
4
Baker Bros. Advisors
New York
|
$28M |
| 5 |
5
Man Group
London,
United Kingdom
|
$13.8M |
